Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study
Article in Cancer Discovery (October 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Cancer Discovery (October 2023)
Article in Experimental Hematology & Oncology (August 2023)
Article in Cytotherapy (April 2023)